A 215,
A-215,
alkylate 215,
alkylate-215,
ANA-12,
219766-25-3,
ANA 12,
ANA12,
N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]-benzo[b]thiophene-2-carboxamide,
AK174158,
TrkB antagonist,
N-[2-[(2-oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide,
N-{2-[(2-oxoazepan-3-yl)carbamoyl]phenyl}-1-benzothiophene-2-carboxamide,
AC1ME2YP,
Maybridge1_001394,
Oprea1_341312,
SCHEMBL17493304,
HMS545H08,
AOB4364,
EX-A815,
CHEBI:140465,
BCP16021,
3443AH,
MFCD00117444,
s7745,
AKOS024458344,
N-(2-((2-oxoazepan-3-yl)carbamoyl)phenyl)benzo[b]thiophene-2-carboxamide,
CCG-222404,
CS-3616,
MCULE-5560854306,
KS-0000185U,
NCGC00379202-06,
ANA-12, >=98% (HPLC),
AS-16798,
BC600701,
DA-43208,
HY-12497,
A-215,
FT-0700267,
J-690263,
N-(2-(2-oxoazepan-3-ylcarbamoyl)phenyl)benzo[b]thiophene-2-carboxamide,
N-[2-[(2-oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide.,
N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide,
Tiplasinin,
C22H21N3O3S,
TUSCYCAIGRVBMD-UHFFFAOYSA-N,
ZINC01044528,
CID2799722,